Baxter International Inc.
BAX Real Time Price USDRecent trades of BAX by members of U.S. Congress
---
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in BAX holdings by institutional investors
Quarterly net insider trading by BAX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$30,000 Jan 06, 2022 Issue: Medicare/Medicaid Health Issues
-
$30,000 Oct 13, 2021 Issue: Health Issues Medicare/Medicaid
-
$30,000 Jul 12, 2021 Issue: Health Issues Medicare/Medicaid
-
$30,000 Apr 08, 2021 Issue: Health Issues Medicare/Medicaid
-
$30,000 Jan 07, 2021 Issue: Medicare/Medicaid Health Issues
BAX Estimated quarterly lobbying spending
BAX Revenue by Segment or Geography
New BAX patent grants
-
Patent Title: Pressure manifold system for dialysis Apr. 18, 2017
-
Patent Title: Sealant applicator with malleable section Apr. 18, 2017
-
Patent Title: Devices, systems, and methods for cleaning, disinfecting, rinsing, and priming blood separation devices and associated fluid lines Apr. 11, 2017
-
Patent Title: Infusion system using optical imager for controlling flow and method thereof Mar. 28, 2017
-
Patent Title: Medical fluid machine with supply autoconnection Mar. 07, 2017
-
Patent Title: Method of performing peritoneal dialysis using pneumatic valves Mar. 07, 2017
-
Patent Title: Networked dialysis system Feb. 28, 2017
-
Patent Title: Antimicrobial housing and cover for a medical device Feb. 21, 2017
-
Patent Title: Dialysis system with cassette based balance chambers and volumetric pumps Feb. 21, 2017
-
Patent Title: Preparations based on fibrinogen and sulfated polysaccharides Feb. 14, 2017
-
Patent Title: Systems and methods for removing air from the patient's peritoneal cavity Jan. 31, 2017
-
Patent Title: Dialysis system with a varying rate ultrafiltration profile Jan. 24, 2017
-
Patent Title: Dialysis connector and cap compatible with gas sterilization Jan. 17, 2017
-
Patent Title: Optimization of nucleation and crystallization for lyophilization using gap freezing Dec. 27, 2016
-
Patent Title: Multiple drug infusion system and method Dec. 27, 2016
-
Patent Title: Method and apparatus for removing air from an article-filled bag with oscillating rings Dec. 13, 2016
-
Patent Title: Method and system for alerting as to potential for bolus condition Dec. 13, 2016
-
Patent Title: Hemostatic sponge Dec. 13, 2016
-
Patent Title: Infusion pump including syringe plunger position sensor Dec. 06, 2016
-
Patent Title: Dialysis system having inventory management including online dextrose mixing Dec. 06, 2016
-
Patent Title: Aqueous compositions and methods for bone hemostasis Dec. 06, 2016
-
Patent Title: Stepper motor driven peritoneal dialysis machine Dec. 06, 2016
-
Patent Title: Nitric oxide scavengers Dec. 06, 2016
-
Patent Title: Dialysis machine with electrical insulation for variable voltage input Nov. 29, 2016
-
Patent Title: Dialysis bag with anti-occlusion feature Nov. 15, 2016
-
Patent Title: Dialysis system with balance chamber prime and rinseback Nov. 01, 2016
-
Patent Title: Optical imaging system with multiple imaging channel optical sensing Oct. 25, 2016
-
Patent Title: Method and apparatus for monitoring and controlling peritoneal dialysis therapy Oct. 25, 2016
-
Patent Title: Packaging system Oct. 11, 2016
-
Patent Title: System and method for performing alternative and sequential blood and peritoneal dialysis modalities Sep. 13, 2016
-
Patent Title: Hemodialysis and peritoneal dialysis systems having electrodialysis and electrodeionization capabilities Sep. 13, 2016
-
Patent Title: Mixing system, kit and mixer adapter Sep. 13, 2016
-
Patent Title: Solenoid pinch valve apparatus and method for medical fluid applications having reduced noise production Sep. 06, 2016
-
Patent Title: Method for optimizing tidal therapies employing ultrafiltrate trending Sep. 06, 2016
-
Patent Title: Hemodialysis system with horizontal cassette roller pumps Aug. 23, 2016
-
Patent Title: Injectable fibrin composition for bone augmentation Aug. 23, 2016
-
Patent Title: Process for making dry and stable hemostatic compositions Aug. 09, 2016
-
Patent Title: Method and composition for removing uremic toxins in dialysis processes Jul. 19, 2016
-
Patent Title: Dialysis treatment devices for removing urea Jul. 12, 2016
-
Patent Title: Dialysis system including peristaltic tubing pumping cassette Jul. 12, 2016
-
Patent Title: System and method for pairing a dialysis machine with peripheral devices Jul. 05, 2016
-
Patent Title: Spray head for two component mixer Jul. 05, 2016
-
Patent Title: Hemostatic sponge Jun. 28, 2016
-
Patent Title: Systems and methods for priming sorbent-based hemodialysis using dialysis fluid Jun. 14, 2016
-
Patent Title: Compositions and methods for drug delivery Jun. 14, 2016
-
Patent Title: Optical imaging assembly and system with optical distortion correction Jun. 07, 2016
-
Patent Title: Acoustic line tracing system and method for fluid transfer system Jun. 07, 2016
-
Patent Title: Methods for preparing fluorinated vinyl ethers May. 31, 2016
-
Patent Title: Container system May. 31, 2016
-
Patent Title: Drip chamber with hydrophobic interior surface May. 31, 2016
Federal grants, loans, and purchases
Estimated quarterly amount awarded to BAX from public contracts
Recent insights relating to BAX
Recent picks made for BAX stock on CNBC
ETFs with the largest estimated holdings in BAX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $BAX stock a Buy, Sell, or Hold?
- What is the price target for $BAX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $BAX stock?
- Who owns the most shares of $BAX stock?
- What funds own $BAX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BAX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
- Address Deerfield, IL
- Market Cap 11.2 billion
- Employees 37,500
- Industrial Classification Surgical & Medical Instruments & Apparatus
We estimate that -- received a compensation of -- in --, making them the highest paid executive at BAX, per a recent SEC DEF 14A filing. We estimate that the median employee at BAXTER INTERNATIONAL INC is paid $70,331.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|